Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,868 | 756 | 86.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,900 | 4 | 11.9% |
| Education | $147.51 | 5 | 0.9% |
| Travel and Lodging | $38.57 | 2 | 0.2% |
| Gift | $13.09 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,030 | 102 | $0 (2024) |
| GE HEALTHCARE | $1,958 | 77 | $0 (2024) |
| Allergan, Inc. | $1,599 | 29 | $0 (2022) |
| UCB, Inc. | $926.17 | 47 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $892.52 | 65 | $0 (2024) |
| Amgen Inc. | $815.42 | 48 | $0 (2022) |
| Eisai Inc. | $695.85 | 19 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $529.83 | 11 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $528.82 | 35 | $0 (2022) |
| Lilly USA, LLC | $498.27 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,263 | 149 | ABBVIE INC. ($724.32) |
| 2023 | $1,706 | 103 | UCB, Inc. ($301.51) |
| 2022 | $1,696 | 96 | GE HealthCare ($242.84) |
| 2021 | $3,407 | 134 | AbbVie Inc. ($882.93) |
| 2020 | $1,932 | 88 | Allergan, Inc. ($754.11) |
| 2019 | $1,051 | 58 | GE HEALTHCARE ($236.45) |
| 2018 | $1,835 | 84 | Sunovion Pharmaceuticals Inc. ($529.83) |
| 2017 | $1,078 | 57 | GE HEALTHCARE ($343.91) |
All Payment Transactions
769 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Genetic Disease | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Genetic Disease | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Immunology | ||||||
| 11/23/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $114.13 | General |
| Category: Neurology | ||||||
| 11/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/26/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Neurology | ||||||
| 10/26/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $15.93 | General |
| 10/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,919 | 13,804 | $920,574 | $336,845 |
| 2022 | 13 | 1,587 | 10,818 | $747,309 | $272,802 |
| 2021 | 18 | 1,704 | 11,008 | $784,447 | $297,664 |
| 2020 | 14 | 1,451 | 7,819 | $555,815 | $209,327 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 507 | 932 | $246,425 | $87,568 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 548 | 940 | $175,800 | $62,230 | 35.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 19 | 10,900 | $138,145 | $54,097 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 194 | 194 | $88,944 | $31,963 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 174 | 206 | $76,381 | $28,093 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 176 | 176 | $61,118 | $21,736 | 35.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 106 | 109 | $47,165 | $18,408 | 39.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 107 | 220 | $43,836 | $17,031 | 38.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 17 | 55 | $19,226 | $7,206 | 37.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 21 | 21 | $16,360 | $6,282 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,797 | $2,045 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 22 | $377.08 | $184.80 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 467 | 889 | $237,231 | $84,528 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 455 | 742 | $141,090 | $49,951 | 35.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 17 | 8,400 | $104,080 | $41,108 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 129 | 161 | $60,987 | $21,960 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 126 | 126 | $58,932 | $21,459 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $41,721 | $14,308 | 34.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 72 | 73 | $32,832 | $12,717 | 38.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 73 | 148 | $30,899 | $12,047 | 39.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 14 | 42 | $14,849 | $5,608 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $15,463 | $5,447 | 35.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 11 | $8,700 | $3,410 | 39.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 11 | 11 | $331.76 | $164.38 | 49.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 32 | $192.00 | $95.16 | 49.6% |
About Dr. Ronald Howard, MD
Dr. Ronald Howard, MD is a Neurology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316940976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Howard, MD has received a total of $15,968 in payments from pharmaceutical and medical device companies, with $3,263 received in 2024. These payments were reported across 769 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,868).
As a Medicare-enrolled provider, Howard has provided services to 6,661 Medicare beneficiaries, totaling 43,449 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Naples, FL
- Active Since 05/27/2005
- Last Updated 12/16/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1316940976
Products in Payments
- UBRELVY (Drug) $2,838
- Aimovig (Biological) $685.58
- Briviact (Drug) $659.67
- NURTEC ODT (Drug) $623.54
- Leqembi (Drug) $602.71
- NUEDEXTA (Drug) $530.02
- APTIOM (Drug) $529.83
- QULIPTA (Drug) $467.99
- ONPATTRO (Drug) $364.14
- AJOVY (Biological) $343.88
- BOTOX (Biological) $311.71
- AIMOVIG (Biological) $288.86
- AMYVID (Drug) $275.25
- AUSTEDO (Drug) $240.89
- OXTELLAR XR (Drug) $231.78
- TROKENDI XR (Drug) $187.83
- Austedo XR (Drug) $180.76
- RYTARY (Drug) $171.83
- ADUHELM (Biological) $165.97
- EMGALITY (Drug) $162.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Naples
Matthew Baker, Md, MD
Neurology — Payments: $1.8M
William Justiz, Md, MD
Neurology — Payments: $135,961
Dr. Igor Reis, M.d, M.D
Neurology — Payments: $22,365
Mark Rubino, Md, MD
Neurology — Payments: $21,523
Dr. Michael Novak, Md, MD
Neurology — Payments: $14,679
Pedro Garciarena, M.d, M.D
Neurology — Payments: $14,132